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In their systematic review of sex differences in respiratory tract infections (RTIs), Falagas et al. 
concluded that males develop RTIs more frequently than females, in particular lower RTIs, and the 
course of the infection is often more severe in males than in females.1 
 In 1997, I reported a meta-analysis of British trials on vitamin C and the common cold which 
gives a complementary viewpoint on sex differences in RTIs.2  In four trials with males, vitamin C 
supplementation reduced common cold incidence by 30% (95% CI: ?40 to ?19%), but had no effect in 
four trials with females (estimate ?5%; 95% CI: ?14 to +4%).  The divergence in the confidence 
intervals suggests different effects on males and females. Three studies reported data for both males and 
females and the largest of these, by Baird et al.3, found highly significant interaction between sex and 
vitamin C effect on common cold incidence (Table 1). The two smaller trials had wide confidence 
intervals that overlapped between males and females.2  Furthermore, in four trials with British males, 
vitamin C reduced recurrent colds during the study period by 46% (?60 to ?26%), but had no effect on 
females.2  In particular, Tyrrell et al.4 found that therapeutic vitamin C during the first cold episode 
reduced subsequent colds in males by 40% (?63 to ?3%),2 but not in females (?7%; ?45 to +54%). The 
Baird et al.3 and Tyrrell et al.4 studies were randomised placebo-controlled double-blind trials and their 
findings cannot be dismissed on methodological grounds. 
 Because large-scale trials give no evidence that high-dose vitamin C supplementation (?1 g/day) 
decreases common cold incidence,2 the findings with British males call for special explanations.  
Several surveys had reported low dietary vitamin C intake in the UK and thus the benefit of 
supplementation may be explained by treating marginal deficiency.2  This explanation is consistent with 
the estimated low daily vitamin C intake in Baird’s study, 50 mg/day, and the particularly low dosage of 
vitamin C supplementation, 80 mg/day.3  Usually plasma and leucocyte vitamin C concentrations are 
lower in males than in females although it is not clear to what extent this is due to dietary and 
physiological differences between the sexes.2  Concluding from the British studies,2-4 it seems that sex 
differences in RTIs may be generated by variations in dietary vitamin C intakes, in addition to the 
factors mentioned by Falagas et al.1  
 Furthermore, in a recent Cochrane review we identified three prophylactic vitamin C trials and 
each of them reported an 80% or greater decrease in pneumonia incidence in the vitamin C group.5  All 
these trials examined males only and the incidence of pneumonia was particularly high. The benefit of 
vitamin C supplementation seemed to be explained by marginal deficiency and by increased 
requirement caused by heavy exertion.5 
 It is obvious that the findings of the common cold trials with British males2 and pneumonia trials 
with males5 cannot be extrapolated to the general population of the western countries. Nevertheless, 
further vitamin C trials are warranted among males with low dietary vitamin C intake. 
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Table 1. Interaction between sex and the effect of vitamin C on common cold incidence 
in British students (Baird et al. 1979)  
 Vitamin C Placebo RR 
(95% CI) 
Interaction 
P 
 Participants No. of  
colds 
Participants No. of  
colds 
  
       
Males 133 184 61 135 0.63 
(0.50-0.78) 0.0001 Females 105 199 51 78 1.24 
(0.95-1.61) 
These data are from refs. 2 and 3. The statistical significance of interaction was 
calculated from the change in ?2×log(likelihood) when the interaction term was added to 
the model (STATA program poisson). 
 
 
 
